Biological and Pharmacological Characterization of Ascorbic Acid and Nicotinamide Chitosan Nanoparticles against insulin-Resistance-Induced Cognitive Defects:A Comparative Study

dc.AffiliationOctober University for modern sciences and Arts (MSA)
dc.contributor.authorAbd-Allah, Hend
dc.contributor.authorNasr, Maha
dc.contributor.authorAhmed-Farid, OmarA.H
dc.contributor.authorEl-Marasy, Salma A
dc.contributor.authorBakeer, Rofanda M
dc.contributor.authorAhmed, Rania F
dc.date.accessioned2021-01-30T13:23:46Z
dc.date.available2021-01-30T13:23:46Z
dc.date.issued2021-01-25
dc.descriptionSJR 2024 0.773 Q1 H-Index 120
dc.description.abstractHigh consumption of industrialized food with high fat content is generally associated with insulin resistance, which in turn causes memory impairment and cognitive decline. Nicotinamide and ascorbic acid are among the promising neuroprotective molecules; however, an appreciable therapeutic activity necessitates the administration of a large dose of either. Therefore, the study aimed to assess if loading them in chitosan nanoparticles in doses 5-10 times lower than the unencapsulated forms would achieve comparable therapeutic results. Animals were fed a high-fat-high-fructose (HFHF) diet for 75 days. The vitamins in their conventional form (100 mg/kg) and the nanoparticles under investigation (10 and 20 mg/kg) were given orally concomitantly with the diet in the last 15 days. The intake of HFHF diet for 75 days led to an insulin-resistant state, with memory impairment, which was verified behaviorally through the object recognition test. This was accompanied by significant reduction in brain insulin-like growth factor 1 (IGF-1), increased acetylcholine esterase activity, increase in the serotonin and dopamine turnover ratio, and increase in oxidative stress and 8-OHdG, indicating cellular DNA fragmentation. Cellular energy was also decreased, and immunohistochemical examination verified the high immunoreactivity in both the cortex and hippocampus of the brain. The administration of nanoparticulated nicotinamide or ascorbic acid with a 10 times lesser dose than the unencapsulated forms managed to reverse all aforementioned harmful effects, with an even lesser immunoreactivity score than the unencapsulated form. Therefore, it can be concluded that nicotinamide or ascorbic acid chitosan nanoparticles can be recommended as daily supplements for neuroprotection in patients suffering from insulin resistance after conduction of clinical investigations.en_US
dc.description.urihttps://www.scimagojr.com/journalsearch.php?q=21100828963&tip=sid&clean=0
dc.identifier.citationHend Abd-Allah, Maha Nasr, Omar, El-Marasy, S. A., Bakeer, R. M., & Ahmed, R. F. (2021). Biological and Pharmacological Characterization of Ascorbic Acid and Nicotinamide Chitosan Nanoparticles against Insulin-Resistance-Induced Cognitive Defects: A Comparative Study. ACS Omega, 6(5), 3587–3601. https://doi.org/10.1021/acsomega.0c05096 ‌
dc.identifier.doihttps://doi.org/https://dx.10.1021/acsomega.0c05096
dc.identifier.otherhttps://doi.org/https://dx.10.1021/acsomega.0c05096
dc.identifier.urihttp://repository.msa.edu.eg/xmlui/handle/123456789/4411
dc.language.isoen_USen_US
dc.publisherAmerican Chemical Societyen_US
dc.relation.ispartofseriesACS OMEGA;6(5):3587-3601
dc.subjectCentral nervous system , Nicotinamide , Nutrition , Organic compounds , Peptides and proteins
dc.titleBiological and Pharmacological Characterization of Ascorbic Acid and Nicotinamide Chitosan Nanoparticles against insulin-Resistance-Induced Cognitive Defects:A Comparative Studyen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
acsomega.0c05096.pdf
Size:
10.44 MB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
51 B
Format:
Item-specific license agreed upon to submission
Description: